top of page

Mood Disorders and Metabolic Inflammatory Illness: 

What Does the Clinician Need to Know

Date: February 24, 2016

Location: Toronto, Ontario, Canada


This archived, self-directed learning activity is available for personal viewing and is based on the live event held in Toronto, Ontario on February, 24, 2016.  The program involved a multidisciplinary faculty of clinician researchers from McMaster and the University of Toronto.  The overarching aim of this learning activity was to provide clinicians with:


  1. An update on the clinical overlap of diabetes, obesity and inflammatory disorders in adults with mood disorders with an emphasis on pathogenetic overlap and mechanistic models.

  2. An evidence-based update and best practices in management of adults with mood disorders who have diabetes, obesity and/or inflammatory conditions.

  3. A detailed review of the role of novel anti-inflammatory and metabolic treatments to improve cognitive function and mood symptom severity in adults with mood disorders

The Panel

Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology 
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit 
University of Toronto 

Rebecca Anglin, MD, PhD, FRCPC
Assistant Professor, 
Department of Psychiatry & Behavioural Neurosciences 
Division of Gastroenterology 
McMaster University 

Julie Lovshin, MD 

Lunenfeld-Tanenbaum Institute,

Mount Sinai Hospital,

Division of Endocrinology and Metabolism

University of Toronto

Sanjeev Sockalingam, MD, MHPE, FRCPC
Associate Professor of Psychiatry 
University of Toronto
Deputy Psychiatrist-in-Chief (TGH & PMH)
Director, TWH Bariatric Surgery Psychosocial Program 
UHN Centre for Mental Health

Rodrigo B. Mansur, MD
Clinical/Research Fellow in Psychiatry 
University of Toronto
Mood Disorders Psychopharmacology Unit 
UHN, Toronto General 

bottom of page